Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shilpa Paul

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 22, 2020
Optimizing patient selection for treatment-free remissionCaitlin R Rausch, Shilpa Paul
Current Oncology Reports|February 10, 2022
Central Nervous System Involvement in Adults with Acute Leukemia: Diagnosis, Prevention, and ManagementShilpa Paul, Nicholas J Short
Cancer|February 28, 2018
Hepatitis C: When high drug prices preclude patient benefitHagop M Kantarjian, Shilpa Paul
Nature Reviews. Clinical Oncology|March 24, 2021
The clinical development of antibody-drug conjugates - lessons from leukaemiaElias Jabbour, Shilpa Paul, Hagop Kantarjian
Mayo Clinic Proceedings|November 6, 2016
Adult Acute Lymphoblastic LeukemiaShilpa Paul, Hagop Kantarjian, Elias J Jabbour
British Journal of Haematology|December 13, 2019
The face of remission inductionShilpa Paul, Caitlin R Rausch, Elias J Jabbour
The Lancet. Haematology|September 29, 2022
The influence of drug prices, new availability of inexpensive generic imatinib, new approvals, and post-marketing research on the treatment of chronic myeloid leukaemia in the USAHagop Kantarjian, Shilpa Paul, Jigar Thakkar, et al.
Cancers|October 29, 2020
CD123 as a Biomarker in Hematolymphoid Malignancies: Principles of Detection and Targeted TherapiesHanadi El Achi, Edouard Dupont, Shilpa Paul, et al.
Future Oncology (London, England)|September 28, 2019
Quizartinib in the treatment of FLT3-internal-tandem duplication-positive acute myeloid leukemiaShilpa Paul, Adam J DiPippo, Farhad Ravandi, et al.
Future Oncology (London, England)|August 5, 2017
Treatment of adult acute lymphoblastic leukemia with inotuzumab ozogamicinShilpa Paul, Caitlin R Rausch, Hagop Kantarjian, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 22, 2020
Optimizing patient selection for treatment-free remissionCaitlin R Rausch, Shilpa Paul
Current Oncology Reports|February 10, 2022
Central Nervous System Involvement in Adults with Acute Leukemia: Diagnosis, Prevention, and ManagementShilpa Paul, Nicholas J Short
Cancer|February 28, 2018
Hepatitis C: When high drug prices preclude patient benefitHagop M Kantarjian, Shilpa Paul
Nature Reviews. Clinical Oncology|March 24, 2021
The clinical development of antibody-drug conjugates - lessons from leukaemiaElias Jabbour, Shilpa Paul, Hagop Kantarjian
Mayo Clinic Proceedings|November 6, 2016
Adult Acute Lymphoblastic LeukemiaShilpa Paul, Hagop Kantarjian, Elias J Jabbour
British Journal of Haematology|December 13, 2019
The face of remission inductionShilpa Paul, Caitlin R Rausch, Elias J Jabbour
The Lancet. Haematology|September 29, 2022
The influence of drug prices, new availability of inexpensive generic imatinib, new approvals, and post-marketing research on the treatment of chronic myeloid leukaemia in the USAHagop Kantarjian, Shilpa Paul, Jigar Thakkar, et al.
Cancers|October 29, 2020
CD123 as a Biomarker in Hematolymphoid Malignancies: Principles of Detection and Targeted TherapiesHanadi El Achi, Edouard Dupont, Shilpa Paul, et al.
Future Oncology (London, England)|September 28, 2019
Quizartinib in the treatment of FLT3-internal-tandem duplication-positive acute myeloid leukemiaShilpa Paul, Adam J DiPippo, Farhad Ravandi, et al.
Future Oncology (London, England)|August 5, 2017
Treatment of adult acute lymphoblastic leukemia with inotuzumab ozogamicinShilpa Paul, Caitlin R Rausch, Hagop Kantarjian, et al.
Pageof 4